limited to

400

Attendees

limited to

300

Companies

80

Speakers

Testimonials

"I was enjoying the conference a lot. This one was one of the most professional conferences I have attended so far because it gathers the best international specialists in this field."

Hanna Hlushchenko, Business Development Director, Cannextra/Cannexpor Pharma Europe

"Our VP Business Development was very impressed with the networking opportunities at the conference."

Debra Senger, Founder and CEO, PhyeinMed

"The conference was fantastic! There were lots of B2B relationships and I encourage anyone to attend."

Mark Lewis, President, Napro Research

How It Works

Through a mix of case-study presentations, interactive roundtable discussions, Q&A sessions and hands-on workshops you will gain a diverse and inspiring perspective. The multi stream format allows you to move freely between the conferences and choose the sessions of most interest and relevance. Create your program from the case studies and interactive round tables.

Move freely between the streams

Customize your program

Attend the sessions of most interest

Get Inspired by the Sessions You Choose from All Streams

Europe
Target Group

Leaders along the hemp and cannabis value chain looking to enter the EU hemp and cannabis industry, or intend to expand their footprint in the EU market

Key Topics
  • Legalization in Europe and particularly Germany
  • Business development
  • Market development
  • Marketing strategies
  • Manufacturing best practices
  • Cultivation best practices
  • Best practice production processes
  • New industry developments
France & UK
Target Group

Leaders along the hemp and cannabis value chain looking to enter the French & UK hemp and cannabis industry, or intend to expand their footprint in the French & UK markets

Key Topics
  • Legalization in France & UK
  • Business development
  • Market development
  • Marketing strategies
  • Manufacturing best practices
  • Cultivation best practices
  • Best practice production processes
  • New industry developments
Mediterranean
Target Group

Leaders along the hemp and cannabis value chain looking to enter the Mediterranean hemp and cannabis industry, or intend to expand their footprint in the Mediterranean market

Key Topics
  • Legalization in the Mediterranean region
  • Business development
  • Market development
  • Marketing strategies
  • Manufacturing best practices
  • Cultivation best practices
  • Best practice production processes
  • New industry developments
Eastern Europe
Target Group

Leaders along the hemp and cannabis value chain looking to enter the Eastern Europe hemp and cannabis industry, or intend to expand their footprint in the Eastern European market

Key Topics
  • Legalization in Eastern Europe
  • Business development
  • Market development
  • Marketing strategies
  • Manufacturing best practices
  • Cultivation best practices
  • Best practice production processes
  • New industry developments

Agenda

Filter by Track:

TUESDAY, JUNE 22ND

9:00

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

No Chairman Yet

If you'd like to be a chairman at this event, this slot is available.

9:15

Regulations and Harmonizations for the EU Market

  • Latest developments in Europe from Bedrocan’s point of view
  • Current regulatory situation
  • Importance of harmonization

Tjalling Erkelens

Founder & CEO
Bedrocan International
The Netherlands

This session is in English

9:45

Complying Regulations for Product Development Aimed for Launch in the EU Market

  • Current requirements for cannabis-derived products
  • Best ways to comply with regulations for products aimed for the EU market
  • Outlook on regulation trends ahead

Parminder Kaur

CEO
RegPak BioPharma
The Netherlands / India

This session is in English

10:00

Poland as a Gateway to the European Medical Cannabis Market

  • Canadian market size, German working culture and Italian fantasy
  • Manual vs automatized - outsourcing in manufacturing of cannabis
  • Education, distribution and reliable partners - key success factors

Zbigniew Pisarski

Founder & Chairman of the Supervisory Board
CanPoland
Poland

This session is in English

10:15

Coffee Break with Networking

10:45

In-Country Medical Cannabis Cultivation Versus Imports: A Comparison Study of the German Industry

  • Current status of in-house production of medical cannabis within Germany
  • How does German medical cannabis compare to imported products?
  • Distribution issues versus the availability of CBD strains

Hendrik Knopp

Managing Director
Aphria Deutschland
Germany

This session is in English

11:15

The Global Cannabis Industry: Regional Import & Export Dynamics

  • Current state & figures of the global cannabis sector
  • Emerging import & export dynamics
  • Opportunities, challenges & insights

Giadha A. DeCarcer

Founder and Executive Chair
New Frontier Data
USA

This session is in English

11:30

Understanding the Correlation between Cannabis Brand Protection and Business Growth

  • 4 processes: Authenticate, Track & Trace, Customer Engagement, Online Brand Monitoring
  • 360° approach to brand protection for the cannabis industry
  • Reducing counterfeit & diversion for immediate ROI
  • How to engage your customer to increase sales

Paul Vitali

VP Business Development EMEA
VerifyMe
USA / Switzerland

This session is in English

11:45

Extraction and Purification of Cannabinoids Using the Most Sustainable Solvent: CO₂

  • Extraction Cost: Why Supercritical CO₂ Extraction (SFE) is the Lowest Cost Method
  • Purification: Why SFC/CO₂ chromatography is the lowest cost for precision ingredients
  • Future: Scaling up processes such as Minor Cannabinoid Isolation and removing impurities/pesticides

Todd Palcic

President
Thar Process
USA

This session is in English

Extraction and Purification of Cannabinoids Using the Most Sustainable Solvent: CO₂

  • Extraction Cost: Why Supercritical CO₂ Extraction (SFE) is the Lowest Cost Method
  • Purification: Why SFC/CO₂ chromatography is the lowest cost for precision ingredients
  • Future: Scaling up processes such as Minor Cannabinoid Isolation and removing impurities/pesticides

Todd Palcic

President
Thar Process
USA

This session is in English

12:00

A Comparison of the Medical Cannabis Industry between North America and Europe

  • Growth potential in these 2 markets
  • Existing regulations and case studies
  • Visions for the future

Daniel Swasbrook

EVP, President Jushi Europe
Jushi Holdings
USA / Portugal

This session is in English

A Comparison of the Medical Cannabis Industry between North America and Europe

  • Growth potential in these 2 markets
  • Existing regulations and case studies
  • Visions for the future

Daniel Swasbrook

EVP, President Jushi Europe
Jushi Holdings
USA / Portugal

This session is in English

Unlocking the French Medical Cannabis Market: A Concerted Effort

  • The French cannabis market: Where are we now?
  • Opportunities and challenges faced by the cannabis industry players in France
  • Medical cannabis education: How France is creating a blueprint for Europe

Hélène Moore

CEO & Founder
pharmBD
France

This session is in English

Unlocking the French Medical Cannabis Market: A Concerted Effort

  • The French cannabis market: Where are we now?
  • Opportunities and challenges faced by the cannabis industry players in France
  • Medical cannabis education: How France is creating a blueprint for Europe

Hélène Moore

CEO & Founder
pharmBD
France

This session is in English

The Meaning of Quality in Indoor Facilities for Cannabis Cultivation

  • How technology impacts the consistency, predictability and yield of indoor controlled environments
  • Integrating these aspects in a total quality management system based on ISO 9001 certification

Alessandro Oliveri

President
Igrox
Italy

This session is in English

The Meaning of Quality in Indoor Facilities for Cannabis Cultivation

  • How technology impacts the consistency, predictability and yield of indoor controlled environments
  • Integrating these aspects in a total quality management system based on ISO 9001 certification

Alessandro Oliveri

President
Igrox
Italy

This session is in English

12:00

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

Legal Conditions for Growing Cannabis in Poland

  • Legislation: Where are we in comparison with Europe?
  • Legal acts projects in the Polish Parliament
  • Moods in the Polish parliament regarding cannabis cultivation

Jarosław Sachajko

Deputy
Polish Parliament of the 8th term
Poland

This session is in English

Legal Conditions for Growing Cannabis in Poland

  • Legislation: Where are we in comparison with Europe?
  • Legal acts projects in the Polish Parliament
  • Moods in the Polish parliament regarding cannabis cultivation

Jarosław Sachajko

Deputy
Polish Parliament of the 8th term
Poland

This session is in English

12:30

The Future of IP in the Cannabis Sector

  • Potentially relevant patent law precedents
  • The current landscape in cannabis IP
  • What does the future hold for cannabis IP?

David Traylor

Senior Managing Director
Golden Eagle Partners
USA

This session is in English

The Future of IP in the Cannabis Sector

  • Potentially relevant patent law precedents
  • The current landscape in cannabis IP
  • What does the future hold for cannabis IP?

David Traylor

Senior Managing Director
Golden Eagle Partners
USA

This session is in English

Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape

  • Overview of EU regulations governing cannabis-derived and CBD-based products
  • Situations in specific EU countries and differences in legislation
  • Cannabis and CBD in France: What is the latest state of play?

Eveline Van Keymeulen

Partner
Latham & Watkins
France

This session is in English

Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape

  • Overview of EU regulations governing cannabis-derived and CBD-based products
  • Situations in specific EU countries and differences in legislation
  • Cannabis and CBD in France: What is the latest state of play?

Eveline Van Keymeulen

Partner
Latham & Watkins
France

This session is in English

Cannabidiol in Clinical Cosmetic Application

  • Cannabidiol in cosmetic preparations and evaluation of effectiveness with respect to the concentration used
  • Clinical tests for the validation of cosmetic efficacy and safety
  • Application of cannabidiol in medical devices

Antonio Mazzucco

Qualified Person
Crystal Hemp
Italy

This session is in English

Cannabidiol in Clinical Cosmetic Application

  • Cannabidiol in cosmetic preparations and evaluation of effectiveness with respect to the concentration used
  • Clinical tests for the validation of cosmetic efficacy and safety
  • Application of cannabidiol in medical devices

Antonio Mazzucco

Qualified Person
Crystal Hemp
Italy

This session is in English

Opportunities for Entering or Investing in the Polish Medical Cannabis Market

  • History of Poland's medical cannabis industry
  • Entering the Polish market
  • What do investors look out for when it comes to Polish medical cannabis companies?

Arek Kuich

Partner
Cannabis Partners
Poland

This session is in English

Opportunities for Entering or Investing in the Polish Medical Cannabis Market

  • History of Poland's medical cannabis industry
  • Entering the Polish market
  • What do investors look out for when it comes to Polish medical cannabis companies?

Arek Kuich

Partner
Cannabis Partners
Poland

This session is in English

13:00

The New Supply Chain: Building Bridges Into and Across Europe

  • Challenges with sourcing cannabis globally
  • How to establish and protect a reliable supply chain
  • Identifying the right time to expand or bolster one's market infrastructure

Nick Pateras

Managing Director Europe
Materia
Europe

This session is in English

The New Supply Chain: Building Bridges Into and Across Europe

  • Challenges with sourcing cannabis globally
  • How to establish and protect a reliable supply chain
  • Identifying the right time to expand or bolster one's market infrastructure

Nick Pateras

Managing Director Europe
Materia
Europe

This session is in English

Cross-Comparison between the French and Italian CBD markets

  • Background of the survey
  • Preferences and use profiles of medical and non-medical consumers
  • Patterns of consumption during COVID times

Davide Fortin

Senior Associate
MPG Consulting (ex Marijuana Policy Group)
France

This session is in English

Cross-Comparison between the French and Italian CBD markets

  • Background of the survey
  • Preferences and use profiles of medical and non-medical consumers
  • Patterns of consumption during COVID times

Davide Fortin

Senior Associate
MPG Consulting (ex Marijuana Policy Group)
France

This session is in English

Italy's Regulatory Status on Cannabis Production

  • The current legal framework in Italy
  • Political currents and approaches to regulation
  • Cannabis in the agricultural, economic and social landscapes

Francesco Mollame

Member of Parliament
Senate of the Republic of Italy
Italy

This session is in English

Italy's Regulatory Status on Cannabis Production

  • The current legal framework in Italy
  • Political currents and approaches to regulation
  • Cannabis in the agricultural, economic and social landscapes

Francesco Mollame

Member of Parliament
Senate of the Republic of Italy
Italy

This session is in English

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

13:30

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How do we comply regulations for products that are aimed to be launched in the EU market? - Parminder Kaur, CEO, RegPak BioPharma


How can cannabinoids be extracted and purified using CO₂? - Todd Palcic, President, Thar Process


How do the North American and European medical cannabis markets compare to each other? - Daniel Swasbrook, EVP, President Jushi Europe, Jushi Holdings


What does the future hold for the cannabis sector in the field of IP? - David Traylor, Senior Managing Director, Golden Eagle Partners


What defines the new supply chain in the cannabis industry? - Nick Pateras, Managing Director Europe, Materia

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How do we comply regulations for products that are aimed to be launched in the EU market? - Parminder Kaur, CEO, RegPak BioPharma


How can cannabinoids be extracted and purified using CO₂? - Todd Palcic, President, Thar Process


How do the North American and European medical cannabis markets compare to each other? - Daniel Swasbrook, EVP, President Jushi Europe, Jushi Holdings


What does the future hold for the cannabis sector in the field of IP? - David Traylor, Senior Managing Director, Golden Eagle Partners


What defines the new supply chain in the cannabis industry? - Nick Pateras, Managing Director Europe, Materia

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What is the current regulatory situation in the EU market? - Tjalling Erkelens, Founder & CEO, Bedrocan International


How will the global cannabis industry look like in the future? - Giadha A. DeCarcer, Founder and Executive Chair, New Frontier Data


How can we unlock the French medical cannabis market? - Hélène Moore, CEO & Founder, pharmBD


Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape - Eveline Van Keymeulen, Partner, Latham & Watkins


What are the consumption habits of French and Italian CBD users? - Davide Fortin, Senior Associate, MPG Consulting (ex Marijuana Policy Group)

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What is the current regulatory situation in the EU market? - Tjalling Erkelens, Founder & CEO, Bedrocan International


How will the global cannabis industry look like in the future? - Giadha A. DeCarcer, Founder and Executive Chair, New Frontier Data


How can we unlock the French medical cannabis market? - Hélène Moore, CEO & Founder, pharmBD


Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape - Eveline Van Keymeulen, Partner, Latham & Watkins


What are the consumption habits of French and Italian CBD users? - Davide Fortin, Senior Associate, MPG Consulting (ex Marijuana Policy Group)

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How does in-country cultivation of medical cannabis in Germany compare to imports? - Hendrik Knopp, Managing Director, Aphria Deutschland


The Meaning of Quality in Indoor Facilities for Cannabis Cultivation - Alessandro Oliveri, President, Igrox


Cannabidiol in Clinical Cosmetic Application - Antonio Mazzucco, Qualified Person, Crystal Hemp


What is Italy's current regulation status on the production of medical cannabis? - Francesco Mollame, Member of Parliament, Senate of the Republic of Italy

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How does in-country cultivation of medical cannabis in Germany compare to imports? - Hendrik Knopp, Managing Director, Aphria Deutschland


The Meaning of Quality in Indoor Facilities for Cannabis Cultivation - Alessandro Oliveri, President, Igrox


Cannabidiol in Clinical Cosmetic Application - Antonio Mazzucco, Qualified Person, Crystal Hemp


What is Italy's current regulation status on the production of medical cannabis? - Francesco Mollame, Member of Parliament, Senate of the Republic of Italy

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is Poland a gateway to the European medical cannabis market? - Zbigniew Pisarski, Founder & Chairman of the Supervisory Board, CanPoland


How can companies protect their brands and how does it help their businesses grow? - Paul Vitali, VP Business Development EMEA, VerifyMe


What are the legal conditions for growing cannabis in Poland? - Jarosław Sachajko, Deputy, Polish Parliament of the 8th term


What are the opportunities for entering or investing in the Polish medical cannabis market? - Arek Kuich, Partner, Cannabis Partners

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is Poland a gateway to the European medical cannabis market? - Zbigniew Pisarski, Founder & Chairman of the Supervisory Board, CanPoland


How can companies protect their brands and how does it help their businesses grow? - Paul Vitali, VP Business Development EMEA, VerifyMe


What are the legal conditions for growing cannabis in Poland? - Jarosław Sachajko, Deputy, Polish Parliament of the 8th term


What are the opportunities for entering or investing in the Polish medical cannabis market? - Arek Kuich, Partner, Cannabis Partners

14:15

Lunch with Networking

15:45

Germany as the Future EU Market Leader for Top Pharmaceutical Quality of Medical Cannabis

  • Supplying patients in Germany with adequate medical cannabis
  • Germany medical cannabis in comparison with other EU markets
  • Future outlook of German medical cannabis in terms of pharmaceutical quality

Dr. Cornelius Maurer

Co‑Founder & Managing Director
Demecan
Germany

This session is in English

Germany as the Future EU Market Leader for Top Pharmaceutical Quality of Medical Cannabis

  • Supplying patients in Germany with adequate medical cannabis
  • Germany medical cannabis in comparison with other EU markets
  • Future outlook of German medical cannabis in terms of pharmaceutical quality

Dr. Cornelius Maurer

Co‑Founder & Managing Director
Demecan
Germany

This session is in English

Political and Legal Issues of Hemp Wellness in France

  • The current French legal and political context
  • The economic significance of the industry in France
  • The challenges and potential ahead

Aurélien Delecroix

President
Syndicat Professionnel du Chanvre
France

Ludovic Rachou

Treasurer
Syndicat Professionnel du Chanvre
France

This session is in English

Aurélien Delecroix

President
Syndicat Professionnel du Chanvre
France

Political and Legal Issues of Hemp Wellness in France

  • The current French legal and political context
  • The economic significance of the industry in France
  • The challenges and potential ahead
This session is in English

Ludovic Rachou

Treasurer
Syndicat Professionnel du Chanvre
France

Malta: An Ideal Jurisdiction for Medical Cannabis

  • Why Malta: Legal and regulatory framework of medical cannabis industry
  • Process
  • Current scenario

Marion Zammit

Head Medical Cannabis Cluster
Malta Enterprise
Malta

This session is in English

Malta: An Ideal Jurisdiction for Medical Cannabis

  • Why Malta: Legal and regulatory framework of medical cannabis industry
  • Process
  • Current scenario

Marion Zammit

Head Medical Cannabis Cluster
Malta Enterprise
Malta

This session is in English

Poland’s Regulatory Status on Medical Cannabis, CBD, and Hemp Products

  • Organization of the market
  • Product registration process
  • Distribution channels and how to effectively distribute products

Anna Slocka

CEO
Medicana
Poland

This session is in English

Poland’s Regulatory Status on Medical Cannabis, CBD, and Hemp Products

  • Organization of the market
  • Product registration process
  • Distribution channels and how to effectively distribute products

Anna Slocka

CEO
Medicana
Poland

This session is in English

16:15

Developments in the Regulatory Environment in Germany and wider Europe

  • Current regulatory market in Germany and the EU market
  • Challenges and opportunities
  • Future outlook on EU regulations in cannabis and CBD

Peter Homberg

Partner
Dentons Europe
Germany

This session is in English

Developments in the Regulatory Environment in Germany and wider Europe

  • Current regulatory market in Germany and the EU market
  • Challenges and opportunities
  • Future outlook on EU regulations in cannabis and CBD

Peter Homberg

Partner
Dentons Europe
Germany

This session is in English

Europe's Investment Climate for Hemp and Cannabis Startups

  • Europe's investment climate for hemp and cannabis startups
  • What investors look out for when investing in startups
  • What startups can do to bring in investments

Henri Sant-Cassia

Co‑Founding Partner
The Cannabis Fund
United Kingdom

This session is in English

Europe's Investment Climate for Hemp and Cannabis Startups

  • Europe's investment climate for hemp and cannabis startups
  • What investors look out for when investing in startups
  • What startups can do to bring in investments

Henri Sant-Cassia

Co‑Founding Partner
The Cannabis Fund
United Kingdom

This session is in English

First Medical Cannabis Exports from Israel Destined for the UK Industry: What Business Opportunities are There?

  • Background of Israel's medical cannabis industry
  • First exports from Israel with UK market as its first destination
  • Business opportunities in global markets

Tamir Gedo

Board Member
BOL Pharma
Israel

This session is in English

First Medical Cannabis Exports from Israel Destined for the UK Industry: What Business Opportunities are There?

  • Background of Israel's medical cannabis industry
  • First exports from Israel with UK market as its first destination
  • Business opportunities in global markets

Tamir Gedo

Board Member
BOL Pharma
Israel

This session is in English

Cannabis 2.0: Next Steps for Medical Cannabis and Cannabis-Infused Product Innovations

  • Advancements in medical cannabis delivery technologies
  • Expanding beyond smoked pot
  • Innovative consumers

Grzegorz Kiełbowicz

CEO
Healthcann
Poland

This session is in English

Cannabis 2.0: Next Steps for Medical Cannabis and Cannabis-Infused Product Innovations

  • Advancements in medical cannabis delivery technologies
  • Expanding beyond smoked pot
  • Innovative consumers

Grzegorz Kiełbowicz

CEO
Healthcann
Poland

This session is in English

16:45

Coffee Break with Networking

17:15

Attracting Investments for Medical Cannabis Startups: A Case Study of Sanity Group's Success Story

  • How were 20 million euros raised? The success story of Sanity Group
  • The outlook of the German market: Changes in the investing environment and best strategies to use
  • Future trends and outlook in the world of medical cannabis startups

Finn Hänsel

Founder & Managing Director
Sanity Group
Germany

This session is in English

Attracting Investments for Medical Cannabis Startups: A Case Study of Sanity Group's Success Story

  • How were 20 million euros raised? The success story of Sanity Group
  • The outlook of the German market: Changes in the investing environment and best strategies to use
  • Future trends and outlook in the world of medical cannabis startups

Finn Hänsel

Founder & Managing Director
Sanity Group
Germany

This session is in English

CBD Business in France: How to Navigate the Complex Regulatory Landscape

  • Legislation and regulatory challenges faced by French CBD players
  • What you need to know to be compliant
  • What are the common mistakes to avoid

Marie Sánchez

Founder and Lawyer
NOOA Avocats
France

This session is in English

CBD Business in France: How to Navigate the Complex Regulatory Landscape

  • Legislation and regulatory challenges faced by French CBD players
  • What you need to know to be compliant
  • What are the common mistakes to avoid

Marie Sánchez

Founder and Lawyer
NOOA Avocats
France

This session is in English

Critical Issues of Medical Cannabis in the Italian Market

  • Supply and distribution in pharmacies
  • Critical points /and improvements
  • New ideas and latest update

Marco Ternelli

CEO
Farmagalenica
Italy

This session is in English

Critical Issues of Medical Cannabis in the Italian Market

  • Supply and distribution in pharmacies
  • Critical points /and improvements
  • New ideas and latest update

Marco Ternelli

CEO
Farmagalenica
Italy

This session is in English

Overview of the Polish Hemp & Cannabis Market: Analysis of Market Competitiveness in Comparison to other EU States

  • Background of the Polish hemp market
  • Analysis of Poland's market competitiveness in hemp and cannabis
  • Future market outlook

Patrycja Bartosz-Burdiak

Co‑Founder & CEO
Orbis Cannabis
Poland

This session is in English

Overview of the Polish Hemp & Cannabis Market: Analysis of Market Competitiveness in Comparison to other EU States

  • Background of the Polish hemp market
  • Analysis of Poland's market competitiveness in hemp and cannabis
  • Future market outlook

Patrycja Bartosz-Burdiak

Co‑Founder & CEO
Orbis Cannabis
Poland

This session is in English

17:45

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

Regulation and Quality Control in CBD Industry

  • Inside Europe's booming CBD market, which CBD brands to trust and how to make sure of the CBD quality?
  • CBD isolate or CBD broad spectrum or CBD full spectrum: How can a consumer know if he is really getting what he is buying?
  • Certificate of analysis and labelling guidelines are key to ensure CBD product quality

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

Regulation and Quality Control in CBD Industry

  • Inside Europe's booming CBD market, which CBD brands to trust and how to make sure of the CBD quality?
  • CBD isolate or CBD broad spectrum or CBD full spectrum: How can a consumer know if he is really getting what he is buying?
  • Certificate of analysis and labelling guidelines are key to ensure CBD product quality

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

Research Towards the Next Generation of Cannabis-Based Products: Molecules, Synergy and Activity

No topics have been added to this session yet

Hinanit Koltai

Research Scientist
Agricultural Research Organization ‑ Volcani Center
Israel

This session is in English

Research Towards the Next Generation of Cannabis-Based Products: Molecules, Synergy and Activity

No topics have been added to this session yet

Hinanit Koltai

Research Scientist
Agricultural Research Organization ‑ Volcani Center
Israel

This session is in English

The Situation of Medical Cannabis Patients in Poland

  • Medical cannabis treatment availability
  • Problems faced by patients in Poland
  • CBD and nutraceutical market in Poland

Dorota Gudaniec

CEO
Max Hemp
Poland

This session is in English

The Situation of Medical Cannabis Patients in Poland

  • Medical cannabis treatment availability
  • Problems faced by patients in Poland
  • CBD and nutraceutical market in Poland

Dorota Gudaniec

CEO
Max Hemp
Poland

This session is in English

18:15

Prospects of Australian Medical Cannabis Products in the German Market

  • Production of medical cannabis extracts in Australia
  • Collaboration with Little Green Pharma: Bringing EU-GMP Australian products into Germany
  • Future prospects of Australian medical cannabis products in the German market

Dr. Stefan Feuerstein

Managing Director
AMP German Cannabis Group
Germany

This session is in English

Prospects of Australian Medical Cannabis Products in the German Market

  • Production of medical cannabis extracts in Australia
  • Collaboration with Little Green Pharma: Bringing EU-GMP Australian products into Germany
  • Future prospects of Australian medical cannabis products in the German market

Dr. Stefan Feuerstein

Managing Director
AMP German Cannabis Group
Germany

This session is in English

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France

  • Fundraising in France for hemp and cannabis, between stigma and poor knowledge
  • Is the Cannabis industry harsher than other industries?
  • Canadian cannabis companies and their impact on investments
  • 2020 and 2021, what will happen?

Franck Milone Delacourt

CEO & Founder
DelleD
France

This session is in English

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France

  • Fundraising in France for hemp and cannabis, between stigma and poor knowledge
  • Is the Cannabis industry harsher than other industries?
  • Canadian cannabis companies and their impact on investments
  • 2020 and 2021, what will happen?

Franck Milone Delacourt

CEO & Founder
DelleD
France

This session is in English

Farm to Pharma: Cultivating Pharmaceutical a-Grade Cannabis to Pharmaceutical Products in Israel and Europe Landscape

  • Best practices in Israel cultivation
  • International regulations
  • Sourced pharmaceutical-grade products

Oren Shuster

Founder
International Medical Cannabis
Israel

This session is in English

Farm to Pharma: Cultivating Pharmaceutical a-Grade Cannabis to Pharmaceutical Products in Israel and Europe Landscape

  • Best practices in Israel cultivation
  • International regulations
  • Sourced pharmaceutical-grade products

Oren Shuster

Founder
International Medical Cannabis
Israel

This session is in English

Hemp as an Opportunity for the Economy: Prospects and Challenges for the Industry

  • CBD and Nutraceuticals in Poland
  • Novel Foods requirements for producers
  • Hemp and cannabinoids in food and food supplements
  • Future trends and opportunities for cannabis market players in this field

Jacek Kramarz

Director of Business Development
HemPoland
Poland

This session is in English

Hemp as an Opportunity for the Economy: Prospects and Challenges for the Industry

  • CBD and Nutraceuticals in Poland
  • Novel Foods requirements for producers
  • Hemp and cannabinoids in food and food supplements
  • Future trends and opportunities for cannabis market players in this field

Jacek Kramarz

Director of Business Development
HemPoland
Poland

This session is in English

18:45

Outlook for CBD Products in EU's Food & Beverage Industry

  • Novel Foods regulation and how it affects the CBD industry
  • Use of CBD products in Europe's F&B industry
  • Outlook ahead

Sebastian Kamphorst

CEO
Becanex
Germany

This session is in English

Outlook for CBD Products in EU's Food & Beverage Industry

  • Novel Foods regulation and how it affects the CBD industry
  • Use of CBD products in Europe's F&B industry
  • Outlook ahead

Sebastian Kamphorst

CEO
Becanex
Germany

This session is in English

When Biotech Disrupts Cannabis Issues

  • Issues with classic indoors, field, greenhouse production
  • Presentation of three alternative biotech production methods
  • Comparison of the three methods
  • Conclusion: History and trends

Franck Pradier

Managing Director
Alkion BioInnovations
France

This session is in English

When Biotech Disrupts Cannabis Issues

  • Issues with classic indoors, field, greenhouse production
  • Presentation of three alternative biotech production methods
  • Comparison of the three methods
  • Conclusion: History and trends

Franck Pradier

Managing Director
Alkion BioInnovations
France

This session is in English

Innovation as a Growth Engine of the Global of Medical Cannabis Industry

  • Innovation as a significant differentiator on the cannabis industry
  • How to integrate innovation in the traditional agricultural and pharmaceutical Industry
  • How to build an innovative and open ecosystem in the low tech industry
  • Tech Transfer technologies between the High-tech industry and the cannabis arena

Rachel Dangur

Founder
CannaCAST IL
Israel

This session is in English

Innovation as a Growth Engine of the Global of Medical Cannabis Industry

  • Innovation as a significant differentiator on the cannabis industry
  • How to integrate innovation in the traditional agricultural and pharmaceutical Industry
  • How to build an innovative and open ecosystem in the low tech industry
  • Tech Transfer technologies between the High-tech industry and the cannabis arena

Rachel Dangur

Founder
CannaCAST IL
Israel

This session is in English

The Polish Hemp Textile Market, Current Status, Prospects and Comparison with other European Countries

  • Current infrastructure, deficiencies, and needs
  • Manufacturing process, from cultivation to fiber
  • Different methods of using hemp straw

Marek Radwański

President
Polish Chamber of Flax and Hemp
Poland

This session is in English

The Polish Hemp Textile Market, Current Status, Prospects and Comparison with other European Countries

  • Current infrastructure, deficiencies, and needs
  • Manufacturing process, from cultivation to fiber
  • Different methods of using hemp straw

Marek Radwański

President
Polish Chamber of Flax and Hemp
Poland

This session is in English

19:15

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Can Germany be the future European market leader in terms of pharmaceutical quality of medical cannabis? - Dr. Cornelius Maurer, Co‑Founder & Managing Director, Demecan


How has the regulatory environment in Germany and wider Europe developed? - Peter Homberg, Partner, Dentons Europe


How can medical cannabis startups attract investments successfully? - Finn Hänsel, Founder & Managing Director, Sanity Group


What are the prospects of Australian-cultivated medical cannabis extracts in Germany? - Dr. Stefan Feuerstein, Managing Director, AMP German Cannabis Group


What are the prospects of CBD products in Europe's food & beverage industry? - Sebastian Kamphorst, CEO, Becanex

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Can Germany be the future European market leader in terms of pharmaceutical quality of medical cannabis? - Dr. Cornelius Maurer, Co‑Founder & Managing Director, Demecan


How has the regulatory environment in Germany and wider Europe developed? - Peter Homberg, Partner, Dentons Europe


How can medical cannabis startups attract investments successfully? - Finn Hänsel, Founder & Managing Director, Sanity Group


What are the prospects of Australian-cultivated medical cannabis extracts in Germany? - Dr. Stefan Feuerstein, Managing Director, AMP German Cannabis Group


What are the prospects of CBD products in Europe's food & beverage industry? - Sebastian Kamphorst, CEO, Becanex

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Political and Legal Issues of Hemp Wellness in France - Aurélien Delecroix, President, Syndicat Professionnel du Chanvre and Ludovic Rachou, Treasurer, Syndicat Professionnel du Chanvre


CBD Business in France: How to Navigate the Complex Regulatory Landscape - Marie Sánchez, Founder and Lawyer, NOOA Avocats


Regulation and Quality Control in CBD Industry - Sébastien Béguerie, CEO & Founder, Alpha‑CAT


How is the investment climate for hemp and cannabis startups like in Europe? - Henri Sant-Cassia, Co‑Founding Partner, The Cannabis Fund


Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France - Franck Milone Delacourt, CEO & Founder, DelleD


When Biotech Disrupts Cannabis Issues - Franck Pradier, Managing Director, Alkion BioInnovations

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Political and Legal Issues of Hemp Wellness in France - Aurélien Delecroix, President, Syndicat Professionnel du Chanvre and Ludovic Rachou, Treasurer, Syndicat Professionnel du Chanvre


CBD Business in France: How to Navigate the Complex Regulatory Landscape - Marie Sánchez, Founder and Lawyer, NOOA Avocats


Regulation and Quality Control in CBD Industry - Sébastien Béguerie, CEO & Founder, Alpha‑CAT


How is the investment climate for hemp and cannabis startups like in Europe? - Henri Sant-Cassia, Co‑Founding Partner, The Cannabis Fund


Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France - Franck Milone Delacourt, CEO & Founder, DelleD


When Biotech Disrupts Cannabis Issues - Franck Pradier, Managing Director, Alkion BioInnovations

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is Malta primed as the future manufacturing hub for medical cannabis exports into the European market? - Marion Zammit, Head Medical Cannabis Cluster, Malta Enterprise


Where are the business opportunities of Israel medical cannabis exports in the UK industry? - Tamir Gedo, Board Member, BOL Pharma


Critical Issues of Medical Cannabis in the Italian Market - Marco Ternelli, CEO, Farmagalenica


Research Towards the Next Generation of Cannabis-Based Products: Molecules, Synergy and Activity - Hinanit Koltai, Research Scientist, Agricultural Research Organization ‑ Volcani Center


Farm to Pharma: Cultivating Pharmaceutical a-Grade Cannabis to Pharmaceutical Products in Israel and Europe Landscape - Oren Shuster, Founder, International Medical Cannabis


Innovation as a Growth Engine of the Global of Medical Cannabis Industry - Rachel Dangur, Founder, CannaCAST IL

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is Malta primed as the future manufacturing hub for medical cannabis exports into the European market? - Marion Zammit, Head Medical Cannabis Cluster, Malta Enterprise


Where are the business opportunities of Israel medical cannabis exports in the UK industry? - Tamir Gedo, Board Member, BOL Pharma


Critical Issues of Medical Cannabis in the Italian Market - Marco Ternelli, CEO, Farmagalenica


Research Towards the Next Generation of Cannabis-Based Products: Molecules, Synergy and Activity - Hinanit Koltai, Research Scientist, Agricultural Research Organization ‑ Volcani Center


Farm to Pharma: Cultivating Pharmaceutical a-Grade Cannabis to Pharmaceutical Products in Israel and Europe Landscape - Oren Shuster, Founder, International Medical Cannabis


Innovation as a Growth Engine of the Global of Medical Cannabis Industry - Rachel Dangur, Founder, CannaCAST IL

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What is Poland's regulatory status on medical cannabis, CBD and hemp products? - Anna Slocka, CEO, Medicana


What are the next steps for Polish medical cannabis and cannabis-infused product innovations? - Grzegorz Kiełbowicz, CEO, Healthcann


Can the Polish hemp and cannabis market match up to other EU markets' competitiveness? - Patrycja Bartosz-Burdiak, Co‑Founder & CEO, Orbis Cannabis


What is the current situation of medical cannabis patients in Poland? - Dorota Gudaniec, CEO, Max Hemp


What are prospects and challenges for the Polish hemp industry? - Jacek Kramarz, Director of Business Development, HemPoland


How does the Polish hemp textile market compare to other European countries? - Marek Radwański, President, Polish Chamber of Flax and Hemp

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What is Poland's regulatory status on medical cannabis, CBD and hemp products? - Anna Slocka, CEO, Medicana


What are the next steps for Polish medical cannabis and cannabis-infused product innovations? - Grzegorz Kiełbowicz, CEO, Healthcann


Can the Polish hemp and cannabis market match up to other EU markets' competitiveness? - Patrycja Bartosz-Burdiak, Co‑Founder & CEO, Orbis Cannabis


What is the current situation of medical cannabis patients in Poland? - Dorota Gudaniec, CEO, Max Hemp


What are prospects and challenges for the Polish hemp industry? - Jacek Kramarz, Director of Business Development, HemPoland


How does the Polish hemp textile market compare to other European countries? - Marek Radwański, President, Polish Chamber of Flax and Hemp

20:00

Summary of the First Day of the Conference and Start-Up Pitches

20:15

Evening Reception Sponsored by Crystal Hemp

Engage in exciting conversations. Strengthen your network after a day full of knowledge sharing, groundbreaking presentations, and interesting conversations. Join delegates and speakers in the relaxed atmosphere of the event venue.

This session is in English

WEDNESDAY, JUNE 23RD

9:00

Introduction by World Class Business Leaders Institute

9:15

Ensuring Quality of Colombia-Grown Cannabis for the European Market: How is it Done?

  • SWOT analysis of the Colombian cannabis cultivation market
  • Supplying the European market with Colombia-grown cannabis
  • Future market trends and opportunities ahead

Oliver Zugel

Founder & CEO
Foliumed
Spain / Colombia

This session is in English

9:45

Natural Extracts Quality: A Challenge for the Development of the Medical Cannabis Market

  • Quality of cannabis raw materials
  • GMP certification to enter the pharmaceutical market
  • The pathway to achieving the quality required by the pharmaceutical industry

Nora Rossini

Scientific Affairs Manager
Linnea
Switzerland

This session is in English

10:00

The European Medicinal Cannabis Market: A Sustainability Perspective from Seeds to Patients

  • TBC

Bernhard Babel

CEO
Eurox Group
Germany

This session is in English

10:15

Presentation Topic to be Confirmed Soon

  • TBC

Bradley Moore

CEO
Global Cannabis Applications Corporation
Canada

This session is in English

10:45

Coffee Break with Networking

11:15

Benefits of Obtaining EU-GMP and FDA-approved Active Pharmaceutical Ingredients (APIs)

  • The Avient Strategy - Putting consumer safety in the DNA
  • Who are you - Compliance defines clients or vice versa?
  • Botanical compliance - Oxymoronic?
  • The Weight - challenges of pleasing multiple regulatory authorities
  • What they don’t tell you

Miles Wright

CEO
Avient Biosciences
USA

This session is in English

Benefits of Obtaining EU-GMP and FDA-approved Active Pharmaceutical Ingredients (APIs)

  • The Avient Strategy - Putting consumer safety in the DNA
  • Who are you - Compliance defines clients or vice versa?
  • Botanical compliance - Oxymoronic?
  • The Weight - challenges of pleasing multiple regulatory authorities
  • What they don’t tell you

Miles Wright

CEO
Avient Biosciences
USA

This session is in English

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

11:30

Distributing German-Cultivated Medical Cannabis Flowers for the German Market on Behalf of the Cannabis Agency

  • Production and cultivation by local cannabis partners
  • Distribution of locally-cultivated cannabis for the German market on behalf of the Cannabis Agency
  • Outlook for supply of medical cannabis flowers in Germany

Johann Benedikt Sons

CEO & Co‑Founder
Cansativa
Germany

This session is in English

Distributing German-Cultivated Medical Cannabis Flowers for the German Market on Behalf of the Cannabis Agency

  • Production and cultivation by local cannabis partners
  • Distribution of locally-cultivated cannabis for the German market on behalf of the Cannabis Agency
  • Outlook for supply of medical cannabis flowers in Germany

Johann Benedikt Sons

CEO & Co‑Founder
Cansativa
Germany

This session is in English

France Experiences Cannabis: Aims and Facts, Hopes and Limitations

  • Ongoing experiment on medical cannabis in France
  • Medical, pharmaceutical and legal basis of the experiment
  • What is (not) expected to come out from this experiment?
  • What will be the next step?
  • Connections between cannabis and hemp sectors

Alexandre Maciuk

Associate Professor
BioCIS, University Paris Sud
Member of France's Temporary Scientific Committee (CST) For Medical Cannabis
France

This session is in English

France Experiences Cannabis: Aims and Facts, Hopes and Limitations

  • Ongoing experiment on medical cannabis in France
  • Medical, pharmaceutical and legal basis of the experiment
  • What is (not) expected to come out from this experiment?
  • What will be the next step?
  • Connections between cannabis and hemp sectors

Alexandre Maciuk

Associate Professor
BioCIS, University Paris Sud
Member of France's Temporary Scientific Committee (CST) For Medical Cannabis
France

This session is in English

Spain and Portugal - A Study of These Neighboring Countries with Vastly Different Market Regulations

  • Overview of Portugal's regulated market landscape and its benefits
  • How to work in the current unregulated market in Spain and the opportunities and challenges one may expect
  • Opportunities in these two markets and the significance in terms of growth for the Iberian Peninsula

Steven George

Business Development Manager
Tilray Portugal
Portugal / Spain

This session is in English

Spain and Portugal - A Study of These Neighboring Countries with Vastly Different Market Regulations

  • Overview of Portugal's regulated market landscape and its benefits
  • How to work in the current unregulated market in Spain and the opportunities and challenges one may expect
  • Opportunities in these two markets and the significance in terms of growth for the Iberian Peninsula

Steven George

Business Development Manager
Tilray Portugal
Portugal / Spain

This session is in English

Poland and North Macedonia as Emerging Markets for Medical Cannabis Business

  • Poland as the second biggest medical cannabis market in Europe: An overview of the current situation, opportunities, and forecast
  • North Macedonia's medical cannabis industry and current status
  • Meeting Europe's pharmaceutical standards
  • Translating North American and European know-how to reach the GMP standards

Zlatko Keskovski

Founder & CEO
Pharmacann International / NYSK Holdings
Poland / North Macedonia

This session is in English

Poland and North Macedonia as Emerging Markets for Medical Cannabis Business

  • Poland as the second biggest medical cannabis market in Europe: An overview of the current situation, opportunities, and forecast
  • North Macedonia's medical cannabis industry and current status
  • Meeting Europe's pharmaceutical standards
  • Translating North American and European know-how to reach the GMP standards

Zlatko Keskovski

Founder & CEO
Pharmacann International / NYSK Holdings
Poland / North Macedonia

This session is in English

12:00

Securing the Supply of Pharmaceutical Cannabis in Germany Through a Fully Vertically-Integrated Distribution Model

  • Current situation of Germany's medical cannabis supply
  • Ensuring adequate supply through vertically-integrated wholesale and distribution model
  • Future outlook ahead

Sebastian Diemer

CEO
Farmako / Agraflora Europe
Germany

This session is in English

Securing the Supply of Pharmaceutical Cannabis in Germany Through a Fully Vertically-Integrated Distribution Model

  • Current situation of Germany's medical cannabis supply
  • Ensuring adequate supply through vertically-integrated wholesale and distribution model
  • Future outlook ahead

Sebastian Diemer

CEO
Farmako / Agraflora Europe
Germany

This session is in English

Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes?

  • Further delay on WHO's recommendations on cannabis-based products: What does this mean for the industry?
  • Future changes in the scope
  • Beyond the substances scheduling

Farid Ghehioueche

Head of Advocacy
FAAAT think & do tank
France

This session is in English

Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes?

  • Further delay on WHO's recommendations on cannabis-based products: What does this mean for the industry?
  • Future changes in the scope
  • Beyond the substances scheduling

Farid Ghehioueche

Head of Advocacy
FAAAT think & do tank
France

This session is in English

Expansion Strategies for European Cannabis Companies

  • Advantages of expanding into countries with high barriers of entry
  • Viable long-term business plans and models
  • Avoiding mistakes made in the past in Canada

Robert Noveski

CEO & Founder
Sinceritas
Germany / North Macedonia

This session is in English

Expansion Strategies for European Cannabis Companies

  • Advantages of expanding into countries with high barriers of entry
  • Viable long-term business plans and models
  • Avoiding mistakes made in the past in Canada

Robert Noveski

CEO & Founder
Sinceritas
Germany / North Macedonia

This session is in English

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

12:30

Portugal Cannabis Laws: An Overview

  • Cultivating and producing in Portugal: Framework and recent developments
  • Portugal and the international trade of cannabis
  • Accessing the Portuguese patients market
  • Hemp and CBD: It’s now or never?
  • Adult-use regulation in a post-COVID world

Joao Gama

Partner
Gama Gloria
Portugal

This session is in English

Portugal Cannabis Laws: An Overview

  • Cultivating and producing in Portugal: Framework and recent developments
  • Portugal and the international trade of cannabis
  • Accessing the Portuguese patients market
  • Hemp and CBD: It’s now or never?
  • Adult-use regulation in a post-COVID world

Joao Gama

Partner
Gama Gloria
Portugal

This session is in English

Engineering Cannabis of the Future: What to Expect

  • Breeding new cannabis varieties: what are the challenges?
  • New Breeding Techniques & Genetic Engineering: how can they help?
  • How far are we from the future?

Ying Shao

CEO & Co‑Founder
Plantik Biosciences
France

This session is in English

Engineering Cannabis of the Future: What to Expect

  • Breeding new cannabis varieties: what are the challenges?
  • New Breeding Techniques & Genetic Engineering: how can they help?
  • How far are we from the future?

Ying Shao

CEO & Co‑Founder
Plantik Biosciences
France

This session is in English

Leveraging on European Reputation and Quality for the Asian and African Markets

  • Growing cannabis in South Africa and utilizing local resources in Asia and Africa
  • Cannsun's business model leveraging on European reputation and quality for other markets
  • Supplying the Greek medical cannabis market

David Parry

Managing Director
Cannsun Medhel Group
Greece

This session is in English

Leveraging on European Reputation and Quality for the Asian and African Markets

  • Growing cannabis in South Africa and utilizing local resources in Asia and Africa
  • Cannsun's business model leveraging on European reputation and quality for other markets
  • Supplying the Greek medical cannabis market

David Parry

Managing Director
Cannsun Medhel Group
Greece

This session is in English

The Possibility of Waste-Free Use of Hemp Under the Concept of Sustainable Development

  • Hemp as a waste-free resource across many sectors
  • Is industrial use of hemp the answer for adverse environmental changes?
  • Cannabis and Corporate Social Responsibility

Marcin Krzyżkowiak

Founder
CannArch
Poland

This session is in English

The Possibility of Waste-Free Use of Hemp Under the Concept of Sustainable Development

  • Hemp as a waste-free resource across many sectors
  • Is industrial use of hemp the answer for adverse environmental changes?
  • Cannabis and Corporate Social Responsibility

Marcin Krzyżkowiak

Founder
CannArch
Poland

This session is in English

13:00

Data Analysis for a Growing European Hemp Market: How Fast is it Actually Growing?

  • History of the European hemp sector
  • The work of EIHA and data analysis of the industry
  • Outlook, future trends and market opportunities

Daniel Kruse

President
European Industrial Hemp Association (EIHA)
Germany

Lorenza Romanese

Managing Director
European Industrial Hemp Association (EIHA)
Belgium

This session is in English

Daniel Kruse

President
European Industrial Hemp Association (EIHA)
Germany

Data Analysis for a Growing European Hemp Market: How Fast is it Actually Growing?

  • History of the European hemp sector
  • The work of EIHA and data analysis of the industry
  • Outlook, future trends and market opportunities
This session is in English

Lorenza Romanese

Managing Director
European Industrial Hemp Association (EIHA)
Belgium

Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role?

  • Talk about the fund we are launching and why we are launching it in Europe and are based in France
  • Overview of EU ecosystem and what kind of new companies are being created in the space and how France is catching up (fast)
  • Overview of why Europe is the "place to be" for medical cannabis and how France can be a part of it
  • Overview of research and development done in cannabinoids as well as the startups that are commercializing products in France
  • Advantages of France vs other geographies for developping tech

Alexandre Ouimet-Storrs

Co‑Founder and Managing Director
Oskare Capital
France

This session is in English

Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role?

  • Talk about the fund we are launching and why we are launching it in Europe and are based in France
  • Overview of EU ecosystem and what kind of new companies are being created in the space and how France is catching up (fast)
  • Overview of why Europe is the "place to be" for medical cannabis and how France can be a part of it
  • Overview of research and development done in cannabinoids as well as the startups that are commercializing products in France
  • Advantages of France vs other geographies for developping tech

Alexandre Ouimet-Storrs

Co‑Founder and Managing Director
Oskare Capital
France

This session is in English

A Distinct Correlation Between Medical Cannabis Consumption and Reduction of Opiate Use

  • Treatment and research in the medical cannabis
  • A distinct correlation between medical cannabis consumption and reduction of opiate use
  • The plant's medical full potential

Lihi Bar-Lev Schleider

Clinical Research Manager
Tikun‑Olam Cannbit Pharmaceuticals
Israel

This session is in English

A Distinct Correlation Between Medical Cannabis Consumption and Reduction of Opiate Use

  • Treatment and research in the medical cannabis
  • A distinct correlation between medical cannabis consumption and reduction of opiate use
  • The plant's medical full potential

Lihi Bar-Lev Schleider

Clinical Research Manager
Tikun‑Olam Cannbit Pharmaceuticals
Israel

This session is in English

Filling in the Market Gap: Polish Hemp Fibre Production for the European Market

  • General outlook of Polish's hemp industry for the past 10 years
  • Spotting the potential business opportunities of Polish's hemp industry
  • Challenges and possible roadblocks when entering the industry

Maciej Kowalski

Co‑Founder
Kombinat Konopny
Poland

This session is in English

Filling in the Market Gap: Polish Hemp Fibre Production for the European Market

  • General outlook of Polish's hemp industry for the past 10 years
  • Spotting the potential business opportunities of Polish's hemp industry
  • Challenges and possible roadblocks when entering the industry

Maciej Kowalski

Co‑Founder
Kombinat Konopny
Poland

This session is in English

13:30

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How can the European medical cannabis market achieve sustainability through a seed-to-patient model? - Bernhard Babel, CEO, Eurox Group


What are the benefits of obtaining EU-GMP and FDA-approved APIs? - Miles Wright, CEO, Avient Biosciences


What are the plans to distribute locally-cultivated medical cannabis flowers for the German market? - Johann Benedikt Sons, CEO & Co‑Founder, Cansativa


How does Farmako's vertically-integrated medical cannabis distribution model help supply Germany's industry? - Sebastian Diemer, CEO, Farmako / Agraflora Europe


Portugal Cannabis Laws: An Overview - Joao Gama, Partner, Gama Gloria


How fast is the European hemp market growing? - Daniel Kruse, President, European Industrial Hemp Association (EIHA) and Lorenza Romanese, Managing Director, European Industrial Hemp Association (EIHA)

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How can the European medical cannabis market achieve sustainability through a seed-to-patient model? - Bernhard Babel, CEO, Eurox Group


What are the benefits of obtaining EU-GMP and FDA-approved APIs? - Miles Wright, CEO, Avient Biosciences


What are the plans to distribute locally-cultivated medical cannabis flowers for the German market? - Johann Benedikt Sons, CEO & Co‑Founder, Cansativa


How does Farmako's vertically-integrated medical cannabis distribution model help supply Germany's industry? - Sebastian Diemer, CEO, Farmako / Agraflora Europe


Portugal Cannabis Laws: An Overview - Joao Gama, Partner, Gama Gloria


How fast is the European hemp market growing? - Daniel Kruse, President, European Industrial Hemp Association (EIHA) and Lorenza Romanese, Managing Director, European Industrial Hemp Association (EIHA)

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the opportunities for Colombia-grown cannabis for the European market? - Oliver Zugel, Founder & CEO, Foliumed


Discussion roundtable topic to be confirmed soon - Bradley Moore, CEO, Global Cannabis Applications Corporation


France Experiences Cannabis: Aims and Facts, Hopes and Limitations - Alexandre Maciuk, Associate Professor, BioCIS, University Paris Sud


Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes? - Farid Ghehioueche, Head of Advocacy, FAAAT think & do tank


Engineering Cannabis of the Future: What to Expect - Ying Shao, CEO & Co‑Founder, Plantik Biosciences


Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role? - Alexandre Ouimet-Storrs, Co‑Founder and Managing Director, Oskare Capital

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the opportunities for Colombia-grown cannabis for the European market? - Oliver Zugel, Founder & CEO, Foliumed


Discussion roundtable topic to be confirmed soon - Bradley Moore, CEO, Global Cannabis Applications Corporation


France Experiences Cannabis: Aims and Facts, Hopes and Limitations - Alexandre Maciuk, Associate Professor, BioCIS, University Paris Sud


Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes? - Farid Ghehioueche, Head of Advocacy, FAAAT think & do tank


Engineering Cannabis of the Future: What to Expect - Ying Shao, CEO & Co‑Founder, Plantik Biosciences


Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role? - Alexandre Ouimet-Storrs, Co‑Founder and Managing Director, Oskare Capital

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How can companies expand their footprint successfully in the Spanish and Portuguese markets? - Steven George, Business Development Manager, Tilray Portugal


How can European cannabis companies expand successfully? - Robert Noveski, CEO & Founder, Sinceritas


How can Europe play an important role in products for Asia and Africa? - David Parry, Managing Director, Cannsun Medhel Group


A Distinct Correlation Between Medical Cannabis Consumption and Reduction of Opiate Use - Lihi Bar-Lev Schleider, Clinical Research Manager, Tikun‑Olam Cannbit Pharmaceuticals

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How can companies expand their footprint successfully in the Spanish and Portuguese markets? - Steven George, Business Development Manager, Tilray Portugal


How can European cannabis companies expand successfully? - Robert Noveski, CEO & Founder, Sinceritas


How can Europe play an important role in products for Asia and Africa? - David Parry, Managing Director, Cannsun Medhel Group


A Distinct Correlation Between Medical Cannabis Consumption and Reduction of Opiate Use - Lihi Bar-Lev Schleider, Clinical Research Manager, Tikun‑Olam Cannbit Pharmaceuticals

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is the quality of natural extracts a challenge for the medical cannabis industry? - Nora Rossini, Scientific Affairs Manager, Linnea


How are Poland and North Macedonia primed as emerging markets for EU's medical cannabis industry? - Zlatko Keskovski, Founder & CEO, Pharmacann International / NYSK Holdings


How can hemp be used sustainably and without waste? - Marcin Krzyżkowiak, Founder, CannArch


Can Polish hemp fibre fill in EU's market gap? - Maciej Kowalski, Co‑Founder, Kombinat Konopny

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is the quality of natural extracts a challenge for the medical cannabis industry? - Nora Rossini, Scientific Affairs Manager, Linnea


How are Poland and North Macedonia primed as emerging markets for EU's medical cannabis industry? - Zlatko Keskovski, Founder & CEO, Pharmacann International / NYSK Holdings


How can hemp be used sustainably and without waste? - Marcin Krzyżkowiak, Founder, CannArch


Can Polish hemp fibre fill in EU's market gap? - Maciej Kowalski, Co‑Founder, Kombinat Konopny

14:15

Lunch with Networking

15:45

The European Union's Harmonization of Access to Non-Medical Cannabis Products

  • Current state of market of non-medical cannabis products within the EU
  • EU's attempt to harmonize access
  • Other challenges and future outlook ahead for non-medical cannabis products

Pavel Kubu

Chief Executive Officer
International Cannabis and Cannabinoids Institute (ICCI)
Czech Republic

Tomas Sadilek

Director of Governmental Affairs
International Cannabis and Cannabinoids Institute (ICCI)
Czech Republic

This session is in English

Pavel Kubu

Chief Executive Officer
International Cannabis and Cannabinoids Institute (ICCI)
Czech Republic

The European Union's Harmonization of Access to Non-Medical Cannabis Products

  • Current state of market of non-medical cannabis products within the EU
  • EU's attempt to harmonize access
  • Other challenges and future outlook ahead for non-medical cannabis products
This session is in English

Tomas Sadilek

Director of Governmental Affairs
International Cannabis and Cannabinoids Institute (ICCI)
Czech Republic

Cosmetics and Beauty Market: CBD is the New Black!

  • What does the regulation state?
  • The boom of the CBD and hemp cosmetics market in the past few years
  • Formulation, registration, production and laboratory testing
  • Strategies to market CBD-based cosmetics

Joanna Weaver-Pélissier

CEO
Be Cann
France

This session is in English

Cosmetics and Beauty Market: CBD is the New Black!

  • What does the regulation state?
  • The boom of the CBD and hemp cosmetics market in the past few years
  • Formulation, registration, production and laboratory testing
  • Strategies to market CBD-based cosmetics

Joanna Weaver-Pélissier

CEO
Be Cann
France

This session is in English

New Breeding Techniques for Improving Cannabis Crops

  • The new breeding techniques allow breeders to obtain new varieties in one generation
  • In vitro culture provides healthy and stronger plants with a greater amount of desired cannabinoids

Veronica Codesido

CCO & Co‑Founder
MIFCO Biosciences
Spain

This session is in English

New Breeding Techniques for Improving Cannabis Crops

  • The new breeding techniques allow breeders to obtain new varieties in one generation
  • In vitro culture provides healthy and stronger plants with a greater amount of desired cannabinoids

Veronica Codesido

CCO & Co‑Founder
MIFCO Biosciences
Spain

This session is in English

Please Visit One of the Other Parallel Streams

16:15

CBD in Europe and the Impact of the Recent ECJ Ruling on Growth in the Sector

  • Downturn of demand and regulatory lack of clarity leading to uncertain market growth in 2020 - What went wrong?
  • Looking towards 2021: Positive ruling in the EU Court of Justice and clarity in the UK regulatory environment
  • US trends as bell-weather for Europe: A look into developments in the US which may be adopted in the European market

Tim Phillips

Managing Director
CBD‑Intel
Spain

This session is in English

CBD in Europe and the Impact of the Recent ECJ Ruling on Growth in the Sector

  • Downturn of demand and regulatory lack of clarity leading to uncertain market growth in 2020 - What went wrong?
  • Looking towards 2021: Positive ruling in the EU Court of Justice and clarity in the UK regulatory environment
  • US trends as bell-weather for Europe: A look into developments in the US which may be adopted in the European market

Tim Phillips

Managing Director
CBD‑Intel
Spain

This session is in English

Growing a Cannabis Brand Online: How Can Data Be Used to Scale?

  • Using data to decide which product(s) to launch and the appropriate distribution channels
  • How data can help companies to target audience and position their brands
  • Optimizing a cannabis brand's growth using SEO and performance marketing

Alexej Pikovsky

CEO & Co‑Founder
Alphagreen Group
United Kingdom

This session is in English

Growing a Cannabis Brand Online: How Can Data Be Used to Scale?

  • Using data to decide which product(s) to launch and the appropriate distribution channels
  • How data can help companies to target audience and position their brands
  • Optimizing a cannabis brand's growth using SEO and performance marketing

Alexej Pikovsky

CEO & Co‑Founder
Alphagreen Group
United Kingdom

This session is in English

Industrial Hemp in a Constantly Growing Economy and its Legislative Challenges

  • The necessary protection of made in Europe
  • The need to develop new genetics
  • Carbon stock in relation to cultivated fields

Rachele Invernizzi

CEO
South Hemp Tecno
Italy

This session is in English

Industrial Hemp in a Constantly Growing Economy and its Legislative Challenges

  • The necessary protection of made in Europe
  • The need to develop new genetics
  • Carbon stock in relation to cultivated fields

Rachele Invernizzi

CEO
South Hemp Tecno
Italy

This session is in English

Please Visit One of the Other Parallel Streams

16:45

Common Difficulties for Small Stakeholders Regarding Industrial Hemp Cultivation

  • Historical background about the symbiotic relation between Portugal and Hemp
  • Law development in Portugal
  • The lack of knowledge from the regulators

António João Costa

Co‑Founder
CannaCasa
Portugal

This session is in English

Common Difficulties for Small Stakeholders Regarding Industrial Hemp Cultivation

  • Historical background about the symbiotic relation between Portugal and Hemp
  • Law development in Portugal
  • The lack of knowledge from the regulators

António João Costa

Co‑Founder
CannaCasa
Portugal

This session is in English

Smokable Hemp in Europe: Legal Framework and Future Perspective

  • Presentation of hemp tobacco subsidiaries in Switzerland and Europe
  • A comparative analysis of the legal framework in Europe
  • The state of the smokable hemp market in France
  • Opportunities for French/European hemp producers

Karolina Willoqueaux

Vice President
Biokonopia
Switzerland

This session is in English

Smokable Hemp in Europe: Legal Framework and Future Perspective

  • Presentation of hemp tobacco subsidiaries in Switzerland and Europe
  • A comparative analysis of the legal framework in Europe
  • The state of the smokable hemp market in France
  • Opportunities for French/European hemp producers

Karolina Willoqueaux

Vice President
Biokonopia
Switzerland

This session is in English

Hemp Application in Eco-Friendly Building

  • The new developed materials comparison to standard building materials
  • Living well-being with hemp building materials

Mariaelena Alessandrini

CEO & Co‑Founder
EDILCANAPA business division of METALINEA
Italy

This session is in English

Hemp Application in Eco-Friendly Building

  • The new developed materials comparison to standard building materials
  • Living well-being with hemp building materials

Mariaelena Alessandrini

CEO & Co‑Founder
EDILCANAPA business division of METALINEA
Italy

This session is in English

Please Visit One of the Other Parallel Streams

17:15

Decreasing Complexity in the European Medical Cannabis Market

  • TBC

Patrick Hoffmann

Co‑Founder
Cantourage
Germany

This session is in English

Decreasing Complexity in the European Medical Cannabis Market

  • TBC

Patrick Hoffmann

Co‑Founder
Cantourage
Germany

This session is in English

Medicinal Cannabis in Luxembourg: Regulatory Challenges in the Heart of Europe

  • What are the current political personnel and administrative bodies in charge of medicinal cannabis in Luxembourg?
  • An overview of the current regulatory framework in the Grand Duchy
  • What is the Consumer Choice Center's perspective on the risk of over-promising of health benefits, and how exaggerated CBD product claims can threaten medicinal legalisation efforts
  • How Luxembourg could open the way forward for better international trade with medical cannabis, particularly in the single market

Bill Wirtz

Senior Policy Analyst
Consumer Choice Center
Belgium

This session is in English

Medicinal Cannabis in Luxembourg: Regulatory Challenges in the Heart of Europe

  • What are the current political personnel and administrative bodies in charge of medicinal cannabis in Luxembourg?
  • An overview of the current regulatory framework in the Grand Duchy
  • What is the Consumer Choice Center's perspective on the risk of over-promising of health benefits, and how exaggerated CBD product claims can threaten medicinal legalisation efforts
  • How Luxembourg could open the way forward for better international trade with medical cannabis, particularly in the single market

Bill Wirtz

Senior Policy Analyst
Consumer Choice Center
Belgium

This session is in English

2021 - Changes in the Cannabis Business: The Story, the Hype, Real Life and Covid19

  • Present and future trends in the global cannabis industry
  • Global outlook for the cannabis industry

Roei Zerahia

Faculty Member at Shankar
Former CEO & Co‑Founder at Canndoc Pharma
Israel

This session is in English

2021 - Changes in the Cannabis Business: The Story, the Hype, Real Life and Covid19

  • Present and future trends in the global cannabis industry
  • Global outlook for the cannabis industry

Roei Zerahia

Faculty Member at Shankar
Former CEO & Co‑Founder at Canndoc Pharma
Israel

This session is in English

Please Visit One of the Other Parallel Streams

17:45

Canadian Cannabis: The Challenges and Opportunities of Being First with Lessons Learned

  • Working with the regulators on policies
  • Fixing the many rules that were contradictory and trying to work with vague ones
  • How patients played a crucial role in legalization and challenges they experienced
  • The evolution of the methods of use both here in Canada and internationally with a focus on what we had, currently have and will have
  • Finding the perfect balance between undersupply and oversupply

Alex Revich

Director
Flowr Corporation
Canada

This session is in English

Canadian Cannabis: The Challenges and Opportunities of Being First with Lessons Learned

  • Working with the regulators on policies
  • Fixing the many rules that were contradictory and trying to work with vague ones
  • How patients played a crucial role in legalization and challenges they experienced
  • The evolution of the methods of use both here in Canada and internationally with a focus on what we had, currently have and will have
  • Finding the perfect balance between undersupply and oversupply

Alex Revich

Director
Flowr Corporation
Canada

This session is in English

A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium

  • Why Luxembourg has a headstart over the rest of the EU
  • Possible changes to come from the recent development in Luxembourg
  • Tobaccolicensing of CBD products as seen in Luxembourg and Belgium

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium

  • Why Luxembourg has a headstart over the rest of the EU
  • Possible changes to come from the recent development in Luxembourg
  • Tobaccolicensing of CBD products as seen in Luxembourg and Belgium

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

Medicalization of Vaporization Technology in the Cannabis Industry

  • Medical advice for a unique formulation
  • Inhalation benefits
  • New delivery method

Avihu Tamir

CEO
Kanabo Group Plc
Israel

This session is in English

Medicalization of Vaporization Technology in the Cannabis Industry

  • Medical advice for a unique formulation
  • Inhalation benefits
  • New delivery method

Avihu Tamir

CEO
Kanabo Group Plc
Israel

This session is in English

Please Visit One of the Other Parallel Streams

18:15

"Cannabis 2.0": What's Next for the Industry?

  • Present trends in the global cannabis industry
  • Adopting the best cannabis practices for the future
  • Global outlook for the cannabis industry

Dr. Zeid Mohamedali

Former Chief Medical Officer
Zenabis
Canada

This session is in English

"Cannabis 2.0": What's Next for the Industry?

  • Present trends in the global cannabis industry
  • Adopting the best cannabis practices for the future
  • Global outlook for the cannabis industry

Dr. Zeid Mohamedali

Former Chief Medical Officer
Zenabis
Canada

This session is in English

What France can Learn from the Danish Medical Cannabis Pilot Program

  • What drove the Minister of Health to support the medical cannabis scheme in Denmark?
  • An overview of the legal framework in Denmark
  • Barriers and challenges encountered in implementing the pilot program
  • An update on the program's progress and the next steps

Rikke Jakobsen

CEO
Cannabis Danmark
Denmark

This session is in English

What France can Learn from the Danish Medical Cannabis Pilot Program

  • What drove the Minister of Health to support the medical cannabis scheme in Denmark?
  • An overview of the legal framework in Denmark
  • Barriers and challenges encountered in implementing the pilot program
  • An update on the program's progress and the next steps

Rikke Jakobsen

CEO
Cannabis Danmark
Denmark

This session is in English

How to Expand the Italian Pharmaceutical and Cannabis Industrial Facility: The Global Opportunities

  • Hemp market and its derivatives
  • Eco circular hemp
  • Global opportunities

Sergio Martines

CEO
Canapar
Canada

This session is in English

How to Expand the Italian Pharmaceutical and Cannabis Industrial Facility: The Global Opportunities

  • Hemp market and its derivatives
  • Eco circular hemp
  • Global opportunities

Sergio Martines

CEO
Canapar
Canada

This session is in English

Please Visit One of the Other Parallel Streams

18:45

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is the EU harmonizing market access to non-medical cannabis products within the region? - Pavel Kubu, Chief Executive Officer, International Cannabis and Cannabinoids Institute (ICCI) and Tomas Sadilek, Director of Governmental Affairs, International Cannabis and Cannabinoids Institute (ICCI)


How will the recent EU Court of Justice ruling affect growth in the CBD sector? - Tim Phillips, Managing Director, CBD‑Intel


Common Difficulties for Small Stakeholders Regarding Industrial Hemp Cultivation - António João Costa, Co‑Founder, CannaCasa


How can complexities in the EU medical cannabis market be reduced? - Patrick Hoffmann, Co‑Founder, Cantourage


Canadian Cannabis: The Challenges and Opportunities of Being First with Lessons Learned - Alex Revich, Director, Flowr Corporation


Where will the cannabis industry be heading towards in the future? - Dr. Zeid Mohamedali, Former Chief Medical Officer, Zenabis

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How is the EU harmonizing market access to non-medical cannabis products within the region? - Pavel Kubu, Chief Executive Officer, International Cannabis and Cannabinoids Institute (ICCI) and Tomas Sadilek, Director of Governmental Affairs, International Cannabis and Cannabinoids Institute (ICCI)


How will the recent EU Court of Justice ruling affect growth in the CBD sector? - Tim Phillips, Managing Director, CBD‑Intel


Common Difficulties for Small Stakeholders Regarding Industrial Hemp Cultivation - António João Costa, Co‑Founder, CannaCasa


How can complexities in the EU medical cannabis market be reduced? - Patrick Hoffmann, Co‑Founder, Cantourage


Canadian Cannabis: The Challenges and Opportunities of Being First with Lessons Learned - Alex Revich, Director, Flowr Corporation


Where will the cannabis industry be heading towards in the future? - Dr. Zeid Mohamedali, Former Chief Medical Officer, Zenabis

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cosmetics and Beauty Market: CBD is the New Black! - Joanna Weaver-Pélissier, CEO, Be Cann


How can data be used to scale up a cannabis brand online? - Alexej Pikovsky, CEO & Co‑Founder, Alphagreen Group


Smokable Hemp in Europe: Legal Framework and Future Perspective - Karolina Willoqueaux, Vice President, Biokonopia


Medicinal Cannabis in Luxembourg : Regulatory Challenges in the Heart of Europe - Bill Wirtz, Senior Policy Analyst, Consumer Choice Center


A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium - Miles Voigt, Chief Sales Officer, AE Grünkraft


What can France learn from the Danish medical cannabis pilot program? - Rikke Jakobsen, CEO, Cannabis Danmark

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cosmetics and Beauty Market: CBD is the New Black! - Joanna Weaver-Pélissier, CEO, Be Cann


How can data be used to scale up a cannabis brand online? - Alexej Pikovsky, CEO & Co‑Founder, Alphagreen Group


Smokable Hemp in Europe: Legal Framework and Future Perspective - Karolina Willoqueaux, Vice President, Biokonopia


Medicinal Cannabis in Luxembourg : Regulatory Challenges in the Heart of Europe - Bill Wirtz, Senior Policy Analyst, Consumer Choice Center


A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium - Miles Voigt, Chief Sales Officer, AE Grünkraft


What can France learn from the Danish medical cannabis pilot program? - Rikke Jakobsen, CEO, Cannabis Danmark

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

New Breeding Techniques for Improving Cannabis Crops - Veronica Codesido, CCO & Co‑Founder, MIFCO Biosciences


Industrial Hemp in a Constantly Growing Economy and its Legislative Challenges - Rachele Invernizzi, CEO, South Hemp Tecno


Hemp Application in Eco-Friendly Building - Mariaelena Alessandrini, CEO & Co‑Founder, EDILCANAPA business division of METALINEA


2021 - Changes in the Cannabis Business: The Story, the Hype, Real Life and Covid19 - Roei Zerahia, Faculty Member at Shankar, Former CEO & Co‑Founder at Canndoc Pharma


Medicalization of Vaporization Technology in the Cannabis Industry - Avihu Tamir, CEO, Kanabo Group Plc


How to Expand the Italian Pharmaceutical and Cannabis Industrial Facility: The Global Opportunities - Sergio Martines, CEO, Canapar

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

New Breeding Techniques for Improving Cannabis Crops - Veronica Codesido, CCO & Co‑Founder, MIFCO Biosciences


Industrial Hemp in a Constantly Growing Economy and its Legislative Challenges - Rachele Invernizzi, CEO, South Hemp Tecno


Hemp Application in Eco-Friendly Building - Mariaelena Alessandrini, CEO & Co‑Founder, EDILCANAPA business division of METALINEA


2021 - Changes in the Cannabis Business: The Story, the Hype, Real Life and Covid19 - Roei Zerahia, Faculty Member at Shankar, Former CEO & Co‑Founder at Canndoc Pharma


Medicalization of Vaporization Technology in the Cannabis Industry - Avihu Tamir, CEO, Kanabo Group Plc


How to Expand the Italian Pharmaceutical and Cannabis Industrial Facility: The Global Opportunities - Sergio Martines, CEO, Canapar

Please Visit One of the Other Parallel Streams

19:30

End of the Conference with Summary

Book Your Tickets

Conference Pass

The ticket includes full access to the Expo and all sessions in all streams, including the evening reception on the first day. This also includes 12 months of full access to all the online features (matched networking and collaboration in the event online think tank, presentations, and the video archive of all World Class Business Leaders Institute conferences). Catering at the event is included. Choose your pass and click on “Book Conference Pass” to access the registration form.

Cultivators, producers, distributors, and retailers can book this pass to attend the conference.

View pass description

Consultants, ancillary businesses, solution and service providers, and investors must book this pass to attend the conference.

View pass description

Employees of public institutions such as the government, military and universities can take advantage of this special price.

Book Conference Pass

World Class Unlimited Online Pass

Access the presentations from this conference online as well as hundreds of other case study videos from global business leaders. The videos are full-length and include the PDFs of the presentation. More videos are added each month with new World Class Business Leaders business transformation conferences bringing best practices to you from around the world. Don't lose this opportunity to stay on top of what business leaders currently do and plan for the future to gain a competitive edge. 12 months of World Class Unlimited are included in any of the Conference Passes.

Book World Class Unlimited Online Pass

Travel & Accommodation

FLEMING'S CONFERENCE HOTEL FRANKFURT
Elbinger Str. 1-3
60487 Frankfurt am Main

For deliveries, please add to the address the following phrase:
"22nd + 23rd of June 2021 & WCBLeaders"

HOW TO GET THERE

FROM CENTRAL STATION:
Choose the underground line U4 to "Bockenheimer Warte" and change at the last stop "Bockenheimer Warte" to the U6 towards Heerstraße, or to the U7 towards Hausen. The station to alight (whether you are taking Line U6 or U7) is "Industriehof". From there, cross the street and subway tracks to follow the Königsberger Straße until the second road where you take a left. The hotel is located on the left side.

FROM THE AIRPORT:
The lines S8 and S9 run from the airport to the main train station (Central Station). At Central Station, choose the underground line U4 to "Bockenheimer Warte" and change at the last stop "Bockenheimer Warte" to the U6 towards Heerstraße, or to the U7 towards Hausen. The station to alight (whether you are taking Line U6 or U7) is "Industriehof". From there, cross the street and subway tracks to follow the Königsberger Straße until the second road where you take a left. The hotel is located on the left side.

PARKING:
You can park your car in the hotel's underground car parking or right in the hotel courtyard for a daily charge of €15.00. If the parking area in the Flemings Conference Hotel is full, we recommend "Brentanobad" as an alternative parking area - the address is Rödelheimer Parkweg, 60489 Frankfurt am Main, Germany.

AIRPORT SHUTTLE:
Two-way airport shuttle is available. The shuttle from the airport to the hotel runs from 5.15am to 10.45pm and is complimentary, while the shuttle from the hotel to the airport runs from 5.30am to 10.30pm, and costs €6 per person.

PREFERENTIAL RATES:
Special rates are available for participants of the event. Double rooms are available at the preferential rate of €115.00 per night while Queen rooms are available at €125.00 per night, both subject to availability and using the special code "WCBLeaders". Please contact the hotel for reservation matters and more information (see below for contact details).

MORE INFORMATION:
To visit the hotel's website and to obtain more information, please click here or contact the hotel via email at frankfurt.conference@flemings-hotels.com

Supported by Partners such as

Think Tank

As a registered attendee, visit the event’s online think tank where you can see your fellow attendees’ profiles and priorities to get in touch, arrange meetings and collaborate with your best networking opportunities. Also, your conference documentation awaits you in this World Class Business Leaders think tank.

Visit the Think Tank

Contributors

Become a Speaker or Sponsor

We are looking for the best practices that shape tomorrow's world. If you would like to contribute to this event as speaker, please fill out the speaker application form here.

If you have already been in contact with the event organization team and are confirming the details of your presentation, please access the speaker questionnaire here.

Get in front of top decision makers of your field! In total, we expect more than € 100M in budgets attending. To get more information and make your business grow, inquire here.

Downloads

Download additional materials about the conference. You will find flyers, logos, banners, signature templates as well as press releases.

Download Conference Materials

Matchmaking-powered Event Experience and Unique Networking Service

100% embedded into the World Class Business platform.

See who you definitely need to network with.

Manage your networking meetings.

Best practices and experts remain only a click away after the event.

...